Crossmark

Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies

Crossref DOI link: https://doi.org/10.1007/s11864-023-01149-1

Published Online: 2023-12-04

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Iurlo, Alessandra

Cattaneo, Daniele

Bucelli, Cristina

Spallarossa, Paolo

Passamonti, Francesco
License Information

Text and Data Mining valid from 2023-12-01

Version of Record valid from 2023-12-01
More Information

Article History

Accepted: 12 November 2023

First Online: 4 December 2023

Compliance with Ethical Standards

:

: The authors declare no competing interests.

: This article does not contain any studies with human or animal subjects performed by any of the authors.

Document is current

Any future updates will be listed below